MedTrace Logo

Serum Sclerostin Level & Treatment of Vitamin D Deficiency

NCT01553344 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2014-12-23

No results posted yet for this study

Summary

The aim of this study is to determine serum sclerostin levels and change in serum sclerostin levels in patients with Vitamin D deficiency treated with calcium and vitamin D.

Healthy premenopausal Patients with Vitamin D deficiency diagnosed and routinely treated with calcium and vitamin D will be included in the study. This is an observational study. The serum sclerostin levels will be measured before and after Vitamin D treatment.

Conditions

  • Endocrine System Diseases
  • Vitamin D Deficiency

Sponsors & Collaborators

  • Bagcilar Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • MUHARREM CIDEM, MD · Bagcilar Training & Research Hospital Istanbul, Turkey

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-04-30
Completion
2013-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01553344 on ClinicalTrials.gov